Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 31, 2026

Back to today

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet 2027 debt maturities.

ABR $2.2B
John Hempton's Newsletter 3 clicks

From X

@StableBread 1 click

Fajasy on X

Neither of the two commercial prospects BWX Technologies $BWXT has named for its BANR microreactor is a data center. 1) Prodigy Clean Energy, a Montreal-based developer of factory-built nuclear plants: Two BANRs for a transportable pilot plant in Belledune, New Brunswick, built mainly at $BWXT’s Ontario plants and running in the early 2030s. New Brunswick’s government signed a letter of intent (LOI) to buy the power. $BWXT and Prodigy are still negotiating a definitive agreement, and the release provides no dollar value. 2) Tata Chemicals Soda Ash: A Wyoming soda ash producer that signed an LOI to explore deploying up to eight BANRs. $BWXT also markets BANR to data centers. However, I found no data center contract, customer, LOI, or revenue in any $BWXT press release from January 2025 through October 2026, in the FY2025 10-K, or in the 2026 10-Qs. $BWXT’s own mentions stop at a product page saying BANR can provide “clean electricity for municipalities, data centers and campuses,” and slides 11 and 25 from its Investor Day on September 29, 2026, which list “AI/data center demand” as a driver of nuclear demand in general. I didn’t hear the phrase “data center” mentioned once during Investor Day, and slide 49 lists data centers in the third phase of $BWXT’s microreactor plan. CEO Rex Geveden said at Investor Day that “the incremental demand from AI right now is 60 GW” and “winning at AI means winning at power, and winning at power probably means having a nuclear solution.” If he’s right, $BWXT benefits by supplying components, fuel, and services to more reactors, not by selling microreactors to data centers. Advanced Reactor Design and Engineering, the product line that includes Project Pele (its prototype microreactor for the Pentagon) and $BWXT’s other microreactor programs, brought in $203.8M in 2024 and $147.1M in 2025, then $52.6M in H1 2026, down from $69.8M a year earlier. At 3.0% of $BWXT’s $1,761.8M of H1 2026 revenue, microreactors are still a small, early business.
@calvinblissett 3 clicks

Calvin Blissett on X

$CHRD: 6.5x FCF, Good CEO, buying back lots of stock, low-cost pure play EP. 8% FCF yield at $60 WTI. No meaningful leverage CHRD trades at ~$142, market cap ~$7.74B, enterprise value ~$8.63B. Dividend yield ~3.7% ($5.20 annual base). Buyback/total shareholder yield is higher: policy returns ≥75% of adjusted free cash flow (mostly buybacks after the base dividend) at current low leverage (<0.5x). On 2026 guidance of ~$1.3B Adj. FCF, this implies a potential total cash return yield in the low-to-mid teens. Valuation is low: ~9.5x TTM P/E, ~7.6x forward P/E, EV/EBITDA ~3.2-3.6x, P/FCF ~6.5x. Analyst consensus PT ~$166-174 (~20%+ upside); highs to $193. Marcellus non-op sale (to POSCO, expected Q4 2026 close) provides ~$550M gross proceeds, sharpening pure-play Williston focus, boosting cash/flexibility for returns or balance-sheet strength, and removing a non-core asset. Reasons for future growth: Flat-to-low absolute oil volumes (maintenance program ~161 MBopd oil) but rising per-share metrics via efficiency and buybacks. Longer laterals (majority of program, including 4-mile) cut costs/breakevens and improve recovery; base production enhancements and lower declines support volumes with less capital. Pure-play focus post-sale plus disciplined consolidator role in the Bakken. Efficiency gains already drove material FCF improvements. LTM Owner’s Earnings (Buffett-style): Roughly Net Income + DD&A + other non-cash charges − maintenance CapEx (and normalized for WC/one-time items). For this E&P, nearly all CapEx is maintenance to offset natural declines, so Owner’s Earnings approximates free cash flow. TTM (to ~Jun 30, 2026): Operating cash flow ~$2.59B, CapEx ~$1.40B → FCF ~$1.19B. DD&A ~$1.54B; Net Income ~$841M. Company-reported adjusted FCF (preferred operational proxy) was strong in 1H26 (~$738M combined Q1+Q2) and has been running at an elevated rate. This is a rigorous, cash-based measure after the capital required to sustain the business. Expected next-12-months Owner’s Earnings: ~$1.3B adjusted free cash flow (company 2026 guidance, including derivatives, at $75 WTI / $3 HH for 2H). Why higher than LTM: stronger realized oil prices vs. prior periods, operational efficiencies (longer laterals, cost controls, base enhancements), volumes at/above high-end of prior guidance, and capital discipline (CapEx held ~$1.4B midpoint). The $550M Marcellus proceeds is one-time cash (not recurring earnings) that further supports returns and balance-sheet optionality. At ≥75% payout, this supports substantial shareholder distributions while maintaining a strong BS. Business simply: Pure-play Williston Basin (Bakken) E&P—largest operator there. Drills oil-focused horizontal wells, produces/sells crude, NGLs, and gas. High-quality inventory; shift to longer laterals improves economics. Management: Danny Brown (CEO; prior Oasis/Anadarko). Track record of efficiency, synergies, disciplined capital allocation, and per-share value creation. Capital allocation: Base dividend + aggressive buybacks under the 75%+ Adj. FCF framework (leverage-dependent). Share count reduced meaningfully; cumulative returns large relative to market cap. Maintenance production focus. Risks: Oil price sensitivity/volatility (primary driver), basin decline/inventory longevity, execution on laterals or M&A, regulatory factors in ND/MT, energy transition headwinds. Margin of safety & upside: Low leverage, high cash generation even at moderate oil prices ($60-70 WTI still supports solid FCF/returns), conservative CapEx, and efficiency gains provide protection. Upside from multiple expansion toward peers/history, continued buyback accretion to per-share metrics, operational outperformance, oil strength, and pure-play clarity. Consensus implies ~20%+ near-term upside; higher in stronger commodity scenarios. Attractive FCF yield + value profile in E&P. Figures based on company results/guidance, market data, and analyst notes as of early October 2026. Oil prices and execution remain key variables.
@calvinblissett 1 click

Calvin Blissett on X

$OC: Trading at an $11B market cap and 5x EBITDA, Owens Corning (NYSE: OC) presents a compelling asymmetric investment thesis as a forecasted >90% probability 2026/2027 "Super El Niño" prepares to drive massive, non-discretionary, insurance-funded roofing repair demand across the Southeast United States. Historical parallels from the 2015–2016 and 2023–2024 El Niño cycles demonstrate clear operating leverage, where severe storm activity doubled roofing EBIT and generated 2x to 3x stock returns within 12 to 24 months. Modeling a 35% (base) to ~50% (bull) EBITDA expansion at a standard 9x EV/EBITDA multiple points to a 2x base-case to nearly 3x bull-case upside over the next 12 months, supported by a ~2.5% dividend yield and tactical plant expansions in Ohio and Alabama. Primary risks include asphalt input price spikes linked to high crude oil prices and ongoing integration or tariff friction from the $3.9B Masonite acquisition. However, the thesis features a deep margin of safety anchored by a elevated trough EBITDA margin floor of 24–34% (up from 13–16% in past cycles), cost-saving vertical integration via in-house asphalt oxidation, and strict insurance policy timelines that compel homeowners to replace damaged roofs regardless of broader macroeconomic weakness.
@aleabitoreddit

Serenity on X

I think almost everything about my $AXTI thesis from 2025 was validated? From AXT's position in the InP substrate bottleneck... Being able to threaten the hyperscaler buildout (per Reuters)... $IQE has been flagging this as a major risk, VPEC and Taiwan epiwafer foundries have been crying over InP substrate bottlenecks. And there's even AXT direct confirmation of partnerships with $LITE and $COHR as the InP substrate supplier. AXT also stated $130m/quarter InP revenue capacity exiting 2027 (~$520m annualized) so that's a massive revenue inflection compared to previously. Now... the biggest question is: How much can AXT price hike? The substrates they make are just such a tiny part of the BOM... but can threaten hyperscaler buildouts with optics. So if they manage to price hike to $SNDK NAND degrees (which they can), then I think AXT could get re-rated a ton from here. But if they end up like Japanese ABF suppliers that are less willing to abuse their position, that's a different story. Will need to do more channel checks to see how that's coming along. But at the very least, I would argue there should be some valuation baseline just due to their critical importance (eg. upstream refinery ownerships, crucible processing, etc) + existing capacity revenue without hikes. TLDR: - Bottleneck thesis was at like ~$500m MC - Upside now comes from price hikes due to duopoly position + ownership of upstream bottlenecks in the InP substrate manufacturing process. (which they can due to low cost of InP substrates in overall costs) - Uncharted territory, we'll see (also a central part of geopolitical tensions so there's always risk there).

Investor Letters

All letters

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $20B
Stock Thoughts 4 clicks

Microsoft's AI Boom Has A Cost

Microsoft’s Azure grew 48% as AI monetization accelerated, but doubled CapEx, largely for CPUs and GPUs, reduced quarterly free cash flow…

MSFT $3.9T
Yiannis Zourmpanos 2 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $465B
Cestrian Capital Research 3 clicks

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $108B
Cestrian Capital Research 1 click
PSN · long

Parsons CORP

Parsons generates roughly half of its $6.4 billion revenue from Federal Solutions, serving defense and intelligence customers.

PSN $5.6B
Value Investors Club

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

AMZN $2.9T
Cestrian Capital Research 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 69 of 272

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

253 firms

Sectors

Ordered by how often our editor reaches for them.